Wanneer primêre lewerkanker geassosieer word met askites, geelsug, verafmetastase, ens., word dit gevorderde primêre lewerkanker genoem. Die behandeling van gevorderde primêre lewerkanker is moeilik, en die kliniese behandelingseffek is nie ideaal nie. Chirurgie is nie 'n opsie vir die behandeling van gevorderde lewerkanker nie, want dit het na limfknope of ander organe versprei.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the immunotherapie drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced lewerkanker. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
